Latest filing published 05 Mar 2018 for Neos Therapeutics, Inc..
Insider track record
No signal scores available.
Dorothy Engelking: trading record in brief
Dorothy Engelking discloses dealings in Neos Therapeutics, Inc. to SEC (Form 4). In total, 3 filings cover trades dated from 28 July 2015 to 1 March 2018.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 5 March 2018 came the latest disclosure, a share grant in Neos Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Dorothy Engelking
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,750 shares0Common StockSEC:0001104659-18-014879:0
- 6,250 shares0Common StockSEC:0001104659-17-029075:0
- 416 sharesCommon StockSEC:0001104659-15-053967:0
3 of 3 declarations
